These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8503494)

  • 21. Effect of steroid, carbogen inhalation, and lipoprostaglandin E1 combination therapy for sudden sensorineural hearing loss.
    Kim MG; Jung YG; Eun YG
    Am J Otolaryngol; 2011; 32(2):91-5. PubMed ID: 20022673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vertigo as a prognostic sign in sudden sensorineural hearing loss.
    Ben-David J; Luntz M; Podoshin L; Sabo E; Fradis M
    Int Tinnitus J; 2002; 8(2):127-8. PubMed ID: 14763225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hearing outcome of sudden sensorineural hearing loss: long-term follow-up.
    Yeo SW; Lee DH; Jun BC; Park SY; Park YS
    Otolaryngol Head Neck Surg; 2007 Feb; 136(2):221-4. PubMed ID: 17275543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
    Kiliç R; Safak MA; Oğuz H; Kargin S; Demirci M; Samim E; Ozlüoğlu LN
    Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden hearing loss.
    Milner RM; Meltzer CR; Brenman AK
    Am J Otol; 1982 Apr; 3(4):375-8. PubMed ID: 7081414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and prognosis of low frequency sensorineural hearing loss without vertigo.
    Jung AR; Kim MG; Kim SS; Kim SH; Yeo SG
    Acta Otolaryngol; 2016; 136(2):159-63. PubMed ID: 26479582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
    Klemm E; Bepperling F; Burschka MA; Mösges R;
    Otol Neurotol; 2007 Feb; 28(2):157-70. PubMed ID: 17255882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
    Suzuki H; Fujimura T; Shiomori T; Ohbuchi T; Kitamura T; Hashida K; Udaka T
    Auris Nasus Larynx; 2008 Jun; 35(2):192-7. PubMed ID: 17826927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.
    Choung YH; Park K; Shin YR; Cho MJ
    Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss.
    Satar B; Hidir Y; Yetiser S
    J Laryngol Otol; 2006 Aug; 120(8):665-9. PubMed ID: 16762093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.
    Kakehata S; Sasaki A; Oji K; Futai K; Ota S; Makinae K; Shinkawa H
    Otol Neurotol; 2006 Aug; 27(5):604-8. PubMed ID: 16788418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?
    Ahn JH; Yoo MH; Yoon TH; Chung JW
    Laryngoscope; 2008 Feb; 118(2):279-82. PubMed ID: 17989574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic sudden sensorineural hearing loss: prognostic factors.
    Xenellis J; Karapatsas I; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Tzagkaroulakis M; Ferekidis E
    J Laryngol Otol; 2006 Sep; 120(9):718-24. PubMed ID: 16854244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
    Van Wijck F; Staecker H; Lefebvre PP
    Acta Otolaryngol; 2007 Oct; 127(10):1012-7. PubMed ID: 17851934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of idiopathic sudden sensorineural hearing loss: experience in newly developing Qatar.
    Salahaldin AH; Bener A; ElHakeem AA; Abdulhadi K
    Int Tinnitus J; 2004; 10(2):165-9. PubMed ID: 15732516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1 in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
    Suzuki H; Fujimura T; Ikeda K; Shiomori T; Udaka T; Ohbuchi T; Nagatani G
    Acta Otolaryngol; 2008 Jan; 128(1):61-5. PubMed ID: 17851957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic sudden sensorineural hearing loss in children.
    Chen YS; Emmerling O; Ilgner J; Westhofen M
    Int J Pediatr Otorhinolaryngol; 2005 Jun; 69(6):817-21. PubMed ID: 15885335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss.
    Hatano M; Uramoto N; Okabe Y; Furukawa M; Ito M
    Acta Otolaryngol; 2008 Feb; 128(2):116-21. PubMed ID: 17851951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saccular damage in patients with idiopathic sudden sensorineural hearing loss without vertigo.
    Hong SM; Byun JY; Park CH; Lee JH; Park MS; Cha CI
    Otolaryngol Head Neck Surg; 2008 Oct; 139(4):541-5. PubMed ID: 18922341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.